Business Wire

Asana BioSciences Announces Acceptance of Its Third IND Application in Oncology

LAWRENCEVILLE, N.J.--(BUSINESS WIRE)--Asana BioSciences, LLC, an oncology-focused, clinical stage biopharmaceutical company, today announced that the FDA has accepted the IND application for ASN003, a ...
Business Wire

Asana BioSciences Announces FDA Acceptance of the IND Application for its Novel SYK-JAK ...

LAWRENCEVILLE, N.J.--(BUSINESS WIRE)--Asana BioSciences, LLC, a clinical stage biopharmaceutical company, today announced that the FDA has accepted the IND application for ASN002, a novel dual SYK-JAK ...